Skip to Content

Drug Interactions between RhoGAM and rubella virus vaccine

This report displays the potential drug interactions for the following 2 drugs:

  • RhoGAM (rho (d) immune globulin)
  • rubella virus vaccine

Edit list (add/remove drugs)

Interactions between your drugs


RHo (D) immune globulin rubella virus vaccine

Applies to: RhoGAM (rho (d) immune globulin) and rubella virus vaccine

RHo (D) immune globulin may interfere with the immune response to rubella virus vaccine. A person who has been treated with RHo (D) immune globulin should generally not be vaccinated for several months with a live vaccine. If vaccination was given shortly before or after RHo (D) immune globulin, a revaccination may be necessary. The immunizing doctor should be informed of recent therapy with RHo (D) immune globulin so that appropriate measures and/or precautions can be taken. It is important to tell the doctor about all other medications being used, including vitamins and herbs. Do not stop using any medications without first talking to the doctor.

Switch to professional interaction data

Drug and food interactions

No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.